Publications by authors named "Muneyoshi Futami"

Claim this Profile
C
CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy.
Sohsuke Meshitsuka, Ryo Ninomiya, Tokiko Nagamura-Inoue, Takashi Okada, Muneyoshi Futami

Regen Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mouse homolog of the mutant WASp responsible for human X-linked neutropenia renders granulopoiesis ineffective.
Masahiro Ikeda, Muneyoshi Futami, Bidisha Chanda, Masayuki Kobayashi, Kiyoko Izawa

Biochem Biophys Res Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD155 and CD112 as possible therapeutic targets of inhibitors for acute myeloid leukemia.
Yuta Kaito, Mitsuhito Hirano, Muneyoshi Futami, Masanori Nojima, Hideto Tamura

Oncol Lett· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-molecule HDAC and Akt inhibitors suppress tumor growth and enhance immunotherapy in multiple myeloma.
Mitsuhito Hirano, Yoichi Imai, Yuta Kaito, Takahiko Murayama, Kota Sato, Muneyoshi Futami

J Exp Clin Cancer Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells.
Muneyoshi Futami, Keisuke Suzuki, Satomi Kato, Saori Ohmae, Yoshio Tahara

PLoS One· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC Inhibitors Exert Anti-Myeloma Effects through Multiple Modes of Action.
Yoichi Imai, Mitsuhito Hirano, Masayuki Kobayashi, Muneyoshi Futami, Arinobu Tojo

Cancers (Basel)· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Doubly-Regulated Vaccinia Virus in a Mouse Xenograft Model of Multiple Myeloma.
Muneyoshi Futami, Kota Sato, Kanji Miyazaki, Kenshi Suzuki, Takafumi Nakamura

Mol Ther Oncolytics· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.
Muneyoshi Futami, Quan-Sheng Zhu, Zakary L Whichard, Ling Xia, Yuehai Ke

Blood· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias.
Bella S Guerrouahen, Muneyoshi Futami, Christos Vaklavas, Jukka Kanerva, Zakary L Whichard

Clin Cancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human herpesvirus 6 variant B infection in adult patients after unrelated cord blood transplantation.
Akira Tomonari, Satoshi Takahashi, Jun Ooi, Tohru Iseki, Kashiya Takasugi, Muneyoshi Futami

Int J Hematol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 years.
Jun Ooi, Tohru Iseki, Satoshi Takahashi, Akira Tomonari, Kashiya Takasugi, Muneyoshi Futami

Br J Haematol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis